Lek launches EUR 28m plant for innovative medicines in Mengeš
Mengeš, 6 July - Slovenian pharma company Lek, a part of the Swiss multinational Novartis, has launched a new centre for the production of active substances for innovative medicines in Mengeš near Ljubljana. The EUR 28m investment is the biggest single investment by Novartis in Slovenia so far.
Mengeš
A new facility of pharmaceutical company Lek launched
Photo: Tamino Petelinšek/STA
Mengeš
A new facility of pharmaceutical company Lek launched
Photo: Tamino Petelinšek/STA
Mengeš
Juan Andres of Novartis speaks at a ceremony launching a new facility of pharma company Lek
Photo: Tamino Petelinšek/STA
Mengeš
Prime Minister Miro Cerar speaks at a ceremony launching a new facility of pharmaceutical company Lek
Photo: Tamino Petelinšek/STA
Mengeš
Chairman of pharma company Lek Vojmir Urlep speaks at a ceremony launching a new facility of Lek
Photo: Tamino Petelinšek/STA
The rest of this news item is available to subscribers.
The news item consists of 1.471 characters (without spaces) or 292 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.